(Q33771660)

29 July 2017

1 reference

title

Airway-rehydrating agents for the treatment of cystic fibrosis: past, present, and future (English)

1 reference

29 July 2017

0 references

Rebecca S Pettit

1

1 reference

PubMed ID

21156814

29 July 2017

Cary E Johnson

series ordinal

2

1 reference

PubMed ID

21156814

29 July 2017

language of work or name

English

0 references

publication date

14 December 2010

1 reference

Annals of Pharmacotherapy

29 July 2017

1 reference

29 July 2017

45

1 reference

29 July 2017

1

1 reference

29 July 2017

49-59

1 reference

29 July 2017

1 reference

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 January 2018

1 reference

Airway clearance devices in cystic fibrosis

21 January 2018

1 reference

Validation of therapeutic bronchoscopic bronchial washing in cystic fibrosis.

21 January 2018

1 reference

Amiloride: still a viable treatment option in cystic fibrosis?

21 January 2018

1 reference

Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis L

21 January 2018

1 reference

Emerging treatments in cystic fibrosis

21 January 2018

1 reference

Hypertonic saline treatment of cystic fibrosis

21 January 2018

1 reference

Rationale for hypertonic saline therapy for cystic fibrosis lung disease

21 January 2018

1 reference

Inhibitory effects of hypertonic saline on P. aeruginosa motility

21 January 2018

1 reference

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis

21 January 2018

1 reference

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

21 January 2018

1 reference

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis

21 January 2018

1 reference

Inhaled mannitol improves lung function in cystic fibrosis.

21 January 2018

1 reference

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study

21 January 2018

1 reference

Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial

21 January 2018

1 reference

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

21 January 2018

1 reference

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis

21 January 2018

1 reference

Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis

21 January 2018

1 reference

Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis

21 January 2018

1 reference

Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis

21 January 2018

1 reference

Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.

21 January 2018

1 reference

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis

21 January 2018

1 reference

Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

21 January 2018

1 reference

Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis

21 January 2018

1 reference

A phase I trial of intranasal Moli1901 for cystic fibrosis

21 January 2018

1 reference

Inhalation of Moli1901 in patients with cystic fibrosis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1P428

1 reference

29 July 2017

1 reference

PubMed ID

21156814